Researchers, Dr. Atheer Majid Rashid and Dr. Janan Muhammad Mohsen / faculty of Pharmacy _ University of Kerbala and Dr. Adeeb Ahmed Al-Zubaidi / Al-Nahrain University, have obtained a patent from Central Agency for Standardization and Quality Control in Iraqi Ministry of Planning that enable them to prove ( effectiveness of montelukast as a topical gel on emerging cutaneous psoriasis in mice).
The patent includes preparation of montelukast gel, its topical application, and evaluation of its potential activity against psoriatic dermatitis.
The patent aims at proving effectiveness of montelukast at concentrations of 0.05% and 0.1%, and it significantly reduces the severity of psoriasis symptoms (severity of redness, scaling, and keratinization of the skin) and reduces inflammatory cytokines that provoke and stimulate the occurrence of psoriasis.
